Nakashima, Masayuki
Takeuchi, Masato
Kawakami, Koji
Funding for this research was provided by:
Pfizer
Article History
Accepted: 7 February 2021
First Online: 26 February 2021
Compliance with ethical standards
:
: Koji Kawakami received an advisory fee from Shin Nippon Biomedical Laboratories, Ltd., JMDC Inc., AGREE Inc.; research funds from Sumitomo Dainippon Pharma Co, Ltd., Pfizer Inc., Stella Pharma Corporation, CMIC Co., Ltd., Suntory Beverage & Food Ltd., Medical Platform Co., Ltd., and Real World Data, Co., Ltd.; and holds stocks of Real World Data, Co., Ltd. There are no patent products under development or marketed products to declare relevant to these companies. Masayuki Nakashima and Masato Takeuchi declare that they have no conflicts of interest.
: The requirement for informed consent was waived due to the anonymous nature of the data.